Poland· PL-100010656
Biotum
A ceftazidime product containing ceftazidimum, registered in Poland by Zakłady Farmaceutyczne POLPHARMA S.A.. The same ATC class is registered in 18 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Ceftazidime is registered in 18 of 19 countries.
Countries holding a registration under ATC J01DD02 (ceftazidime), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 10 of them publish a price we can compare per daily dose
Ceftazidime · ATC J01DD02
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of ceftazidime costs, country by country.
Normalised to the WHO defined daily dose (4 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Ceftazidime · price per daily dose (4 g)
USD · FX 28 Sept 2026
- CH Switzerland$129.98
The record
At a glance
URPL (Poland)- Active substance
- Ceftazidimum
- Manufacturer
- Zakłady Farmaceutyczne POLPHARMA S.A.
- Country
- Poland (PL)
- ATC code
- J01DD02
- ATC class
- Ceftazidime
- Defined daily dose
- 4 g, P
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin05909990360918
- gtin05903060623651
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
155 interactions on record for ceftazidime.
Graded by severity as the source publishes them — 34 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Ceftazidime · interactions on record
155 records
- 34 moderate
- 121 info
Most severe, free to view
- Sodium picosulfateA06AB08moderate
- NeomycinA07AA01moderate
- StreptomycinA07AA04moderate
- Amphotericin BA07AA07moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Ceftazidime in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomCeftazidime 500mg powder for solution for injection vialsStravencon Ltd
- FinlandCeftazidim PharmcomPharmcom Oy
- BelgiumCeftazidim Fresenius Kabi 500 mgFresenius Kabi
- CzechiaCEFTAZIDIME HAMELNhameln pharma gmbh, Hameln
- SpainCEFTAZIDIMA LDP TORLAN 500 mg POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE EFGLdp Laboratorios Torlan S.A.
- SwedenCeftazidim hameln 500 mg Pulver till injektionsvätska, lösningHameln Pharma gmbh
- FranceCEFTAZIDIME ARROW 1 g, poudre pour solution injectable (IM,IV)EUGIA PHARMA (MALTA) (MALTE)
- GermanyCeftazidim Dali PharmaMylan Germany Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Ceftazidim Aptapharma, Ceftazidim Hameln
- Belgium · Ceftazidim Fresenius Kabi, Ceftazidim Hameln
- Bulgaria · Алфагем, Зидимцеф
- Cyprus · Alfagem, Cezid
- Czechia · Altecim, Ceftazidim Aptapharma
- Germany · Ceftazidim Dr. Eberth, Ceftazidim Hameln
- Denmark · Ceftazidim Fresenius Kabi, Ceftazidim Hameln
- Estonia · Altecim, Ceftazidime Fresenius Kabi
- Spain · Alfagem, Ceftazidima Kabi
- Finland · Ceftazidim Fresenius Kabi, Ceftazidim Hameln
- France · Ceftazidime Arrow, Ceftazidime Enfants Et Nourrissons Panpharma
- United Kingdom (Northern Ireland) · Ceftazadime, Ceftazidime Cox Pharmaceutical
- Greece · Alfagem, Ceftaridem
- Croatia · Altecim, Cefaz
- Hungary · Ceftazidim Aptapharma, Ceftazidim Kabi
- Ireland · Ceftazidime Hameln, Ceftazidime Hikma Farmacêutica
- Iceland · Ceftazidim Fresenius Kabi, Ceftazidima Normon
- Italy · Ceftazidima Almus, Ceftazidima Astro-Pharma
- Lithuania · Biotum, Ceftazidime Kabi
- Luxembourg · Ceftazidim Fresenius Kabi, Glazidim
- Latvia · Ceftazidime Fresenius Kabi, Ceftazidime Mip
- Malta · Alfagem, Ceftazidima Fresenius
- Netherlands · Ceftazidim (Im/Iv) Mip, Ceftazidim (Iv) Mip
- Norway · Ceftazidim Fresenius Kabi, Ceftazidim Hameln
- Portugal · Alfagem, Ceftazidima Accord
- Romania · Alfagem, Ceftamil
- Sweden · Ceftazidim Hameln, Fortum
- Slovenia · Ceftazidim Aptapharma, Ceftazidim Kabi
- Slovakia · Ceftazidim Ash, Ceftazidim Hameln
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/9808dd5d-cb96-4e51-83bb-c9c2a9387556 GET /v1/drugs/9808dd5d-cb96-4e51-83bb-c9c2a9387556?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Proszek do sporządzania roztworu do wstrzykiwań",
"source": "urpl",
"strength": "500 mg",
"packaging": "05909990360918 ¦ Lz ¦ 43514\n1 fiol. proszku\n05903060623651 ¦ Lz ¦ 152402\n10 fiol.",
"substance": "Ceftazidimum 500 mg",
"common_name": "Ceftazidimum",
"pl_product_id": "100010656",
"pozwolenie_nr": "03609",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about ceftazidime.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.